A major goal of the Immunology Core is to provide relevant immunologic assays and reagents for basic and clinical investigations of HIV and AIDS. This Core furthers understanding of the immunopathogenesis and pathogenesis of HIV infection and AIDS, provides new approaches toward understanding cellular and humoral responses to HIV, determines the effects of different anti-retroviral regimens on reconstitution of immunologic responses in HIV-infected subjects, determines the effects of immunotherapy or gene therapy on reconstitution of immunologic responses or on altering the clinical course in HIV-infected subjects receiving antiretroviral therapy, and develops HIV vaccine strategies. The Immunology Core (IC) offers a wide range of services to benefit all CFAR members performing H/V-related immunological research. Our services can be subdivided into two major groups: Self and Full Service. The self-service section of the Core prepares validated reagents and materials that are widely used among the member labs of the CFAR. These services include purification of primary human blood cells and antibody production, purification, labeling and enzymatic digestion. During the course of this application, the IC will create HIV-specific tetramer reagents. In addition, training is available for culture and transfection of primary cells, ELISA, and ELISPOT assays. The Full Service section will perform standard immunological assays using AACTG and PACTG approved protocols on samples provided by CFAR members. In addition, a number of flow cytometry-based assays including phenotyping, intracellular cytokine measurements and live sorting of both infectious and non-infectious materials can be performed by highly experienced technicians using the state-of-art equipment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-09
Application #
7456545
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2007-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
9
Fiscal Year
2007
Total Cost
$298,129
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Brocca-Cofano, Egidio; Xu, Cuiling; Wetzel, Katherine S et al. (2018) Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques. J Virol 92:
Costea, Paul I; Hildebrand, Falk; Arumugam, Manimozhiyan et al. (2018) Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 3:8-16
Page, Kathleen R; Grieb, Suzanne Dolwick; Nieves-Lugo, Karen et al. (2018) Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. Lancet HIV 5:e597-e604
Opondo, Philip R; Ho-Foster, Ari R; Ayugi, James et al. (2018) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. AIDS Behav 22:1503-1516
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351

Showing the most recent 10 out of 775 publications